Abstract: Objective To investigate the clinical efficacy of Furongtongmai capsule in the treatment of diabetic peripheral neuropathy. Methods 97 cases of patients with diabetic peripheral neuropathy were diagnosed from January 2013 to January 2015, which were randomly divided into observation group(n=49)and control group(n=48). The control group were treated with western medicine treatment and the observation group were treated with Furongtongmai capsule on the basis of the treatment in the control group.Two sets of treatments were three months. A comparison of the clinical efficacy, symptom score before and after the treatment, TCSS score, nerve conduction velocity and Security in both groups were made. Results The total effective rate in the observation group was 83.67% and that in the control group ws 64.58%, there was a statistical significance(P<0.05); after the treatments, the symptom score and TCSS score in both groups were significantly better than that of the before treatment, and the symptom score and TCSS score in the observation group were significantly superior to that of the control group(P<0.05). There was no difference in bilateral peroneal nerve motor nerve and sensory nerve of transmission speed before the treatment(P>0.05). The NCV in both groups were significantly improved after the treatment(P>0.05), and the mend matters in the observation group were significantly superior to the control group(P<0.05). Conclusion The clinical efficacy of the Furongtongmai capsule combined with western medicine for nourishing the nerves and improving micro-circulation of conventional scheme is significant, which can significantly improve the clinical symptoms and neuropathy, it is worthy to be popularized and applied.

Key words: Furongtongmai capsule, diabetic peripheral neuropathy, clinical curative effect